[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
Views 664
Citations 0
Correction
May 2015

Incorrect Drug Name

JAMA Oncol. 2015;1(2):255. doi:10.1001/jamaoncol.2015.1156

In the Viewpoint titled “Imatinib—A New Tyrosine Kinase Inhibitor for First-Line Treatment of Chronic Myeloid Leukemia in 2015” published online March 12, 2015, in JAMA Oncology (doi:10.1001/jamaoncol.2015.50), an incorrect drug name appeared in the last sentence of the third paragraph. The drug name “nilotinib” should be replaced with “dasatinib.” This article was corrected online.

×